The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga.
Osmotica Pharmaceuticals OSMT is a fully integrated biopharmaceutical company headquartered in Dublin, Ireland. The company focuses on women’s health, neurology and generic drug formulations.
Osmotica Pharmaceuticals OSMT 36.7% Change
At press time, OSMT was up 1.04 after remaining flat for much of the week. The stock nearly reached $5.00 after the announcement of a major acquisition. The stock, however, fell slightly where it currently sits around 3.88. Year-to-date, OSMT has remained in the nearly $5.00 to just under $3.00 range.
Why is OSMT Moving?
OSMT stock recently saw massive gains after it announced the purchase of Alora Pharma out of Metro Atlanta for $110 million. With the purchase including a manufacturing facility, Osmotica is positioning itself to grow in the immediate future.
Where to Buy Osmotica Pharmaceuticals Stock
When you are ready to buy OSMT stock, use this list of preferred brokers to get the best results, quality information and impeccable customer support.
Broker |
Best For |
Overall Rating |
Start Trading |
Intermediate Traders |
4.5 Stars |
||
Lowest Fees |
5 Stars |
||
Beginner Traders |
4 Stars |
||
Active Traders |
5 Stars |
||
Day Traders |
5 Stars |
Stay Ahead of the Game on OSMT
When you use Benzinga Pro, you can stay ahead of the game on any stock, including OSMT. You can see real-time and historical information for any company, track stocks and make wise decisions to diversify your portfolio and increase profits.
Data for Osmotica Pharmaceuticals as of June 25, 2021
Summary of Osmotica Pharmaceuticals as of June 25, 2021:
- Price Change: $2.84 to $3.88
- 52 Week Low: $2.74
- 52 Week High: $9.67
- Market Cap: $242.1M
Significant Dates for Osmotica Pharmaceuticals:
- Next Earnings Date: 8/10/21
- Last Earnings Date: 5/13/21
- Ex-Dividend Date: No upcoming dividends
- Dividend Payment Date: No upcoming dividends
Technical Data of Osmotica Pharmaceuticals as of June 25 2021:
- RSI: 77.04 ⮕ Neutral
- MACD: Signal Line Buy Over MACD (0.03) ⮕ Bearish
- Bollinger Bands: Price $3.88, 20-Day SMA $2.94, Lower Band $2.78, Upper Band $3.10 ⮕ Neutral
The preceding post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Although the piece is not and should not be construed as editorial content, the sponsored content team works to ensure that any and all information contained within is true and accurate to the best of their knowledge and research. This content is for informational purposes only and not intended to be investing advice.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.